CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX)
CUSIP: 230770109
Q3 2021 13F Holders as of 30 Sep 2021
- Type / Class
- Equity / Common stock
- Shares outstanding
- 15,075,924
- Total 13F shares
- 2,767,210
- Share change
- -172,607
- Total reported value
- $7,429,000
- Price per share
- $2.68
- Number of holders
- 20
- Value change
- -$468,259
- Number of buys
- 4
- Number of sells
- 11
Quarterly Holders Quick Answers
What is CUSIP 230770109?
CUSIP 230770109 identifies CPIX - CUMBERLAND PHARMACEUTICALS INC - Common stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 230770109:
Top shareholders of CPIX - CUMBERLAND PHARMACEUTICALS INC - Common stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
5%
|
755,500
|
$2,149,000 | — | 30 Jun 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
4.7%
|
701,463
|
$1,996,000 | — | 30 Jun 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.6%
|
396,024
|
$1,127,000 | — | 30 Jun 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.6%
|
391,596
|
$1,115,000 | — | 30 Jun 2021 | |
| BERKSHIRE ASSET MANAGEMENT LLC/PA |
13F
|
Company |
1.1%
|
170,830
|
$486,000 | — | 30 Jun 2021 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
1.1%
|
168,406
|
$480,000 | — | 30 Jun 2021 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1%
|
153,387
|
$436,000 | — | 30 Jun 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.34%
|
51,493
|
$146,000 | — | 30 Jun 2021 | |
| Sterling Financial Planning, Inc. |
13F
|
Company |
0.15%
|
22,031
|
$63,000 | — | 30 Jun 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.13%
|
20,221
|
$58,000 | — | 30 Jun 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.13%
|
19,843
|
$56,000 | — | 30 Jun 2021 | |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC |
13F
|
Company |
0.11%
|
16,246
|
$46,000 | — | 30 Jun 2021 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.09%
|
13,296
|
$38,000 | — | 30 Jun 2021 | |
| ARIEL INVESTMENTS, LLC |
13F
|
Company |
0.08%
|
12,033
|
$34,000 | — | 30 Jun 2021 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.07%
|
10,700
|
$30,000 | — | 30 Jun 2021 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.07%
|
10,205
|
$29,000 | — | 30 Jun 2021 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0.07%
|
10,000
|
$28,000 | — | 30 Jun 2021 | |
| Jonathan Griggs |
3/4/5
|
Director |
—
class O/S missing
|
14,803
|
$25,165 | — | 17 Mar 2021 | |
| Michael Bonner |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
11,720
|
$19,924 | — | 17 Mar 2021 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.03%
|
5,198
|
$15,000 | — | 30 Jun 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
3,160
|
$9,000 | — | 30 Jun 2021 | |
| Oakworth Capital, Inc. |
13F
|
Company |
0.02%
|
3,052
|
$9,000 | — | 30 Jun 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
2,000
|
$6,000 | — | 30 Jun 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
780
|
$2,000 | — | 30 Jun 2021 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
730
|
$2,000 | — | 30 Jun 2021 | |
| UBS Group AG |
13F
|
Company |
0%
|
465
|
$1,000 | — | 30 Jun 2021 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0%
|
443
|
$1,000 | — | 30 Jun 2021 | |
| FMR LLC |
13F
|
Company |
0%
|
422
|
$1,000 | — | 30 Jun 2021 |
Institutional Holders of CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX) as of Q3 2021
As of 30 Sep 2021,
CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,767,210 shares.
The largest 10 holders included
DIMENSIONAL FUND ADVISORS LP, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, BlackRock Inc., BERKSHIRE ASSET MANAGEMENT LLC/PA, ACADIAN ASSET MANAGEMENT LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, Sterling Financial Planning, Inc., and NORTHERN TRUST CORP.
This page lists
20
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
24
Q3 2021 holders
20
Holder diff
-4
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 Value $ | Q3 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.